Shionogi & Co., Ltd. (Headquartered in Osaka, Japan; CEO: Isao Teshirogi, Ph.D.; referred to as “Shionogi” hereafter) has initiated the second phase of collaboration with Nagasaki University (Located in Nagasaki, Nagasaki Prefecture; President: Takeshi Nagayasu), focusing on comprehensive cooperation in…
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) has initiated dosing for the first patient in the STARLIGHT™ 2 Phase 3 pivotal study for fezolinetant, an investigational oral, nonhormonal compound aimed at addressing vasomotor symptoms (VMS) linked…
Vertex Pharmaceuticals (Nasdaq: VRTX) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a favorable opinion regarding the expansion of the label for KALYDECO® (ivacaftor) to include the treatment…
Bristol Myers Squibb (NYSE: BMY) has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Reblozyl® (luspatercept) for the treatment of adult patients with transfusion-dependent anemia due to…
Carlos Mercado experienced a sudden onset of symptoms reminiscent of a heart attack while settling down for an evening of television in 2022. The racing heart, chest pain, and cold sweats mirrored a previous episode he had endured over a…
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical-stage pharmaceutical company specializing in the discovery, development, and commercialization of oral, small molecule protease inhibitors, has announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted the Innovation Passport…
Today, the World Health Organization (WHO) has unveiled guidelines and tools aimed at enhancing small-scale water supplies. The newly introduced Guidelines for drinking water quality: small water supplies, along with associated Sanitary inspection packages, are designed to elevate water quality…
Zoetis, a global leader in animal health, has announced its financial results for the fourth quarter and full year 2023, along with full-year guidance for 2024. In the fourth quarter of 2023, Zoetis reported revenue of $2.2 billion, marking an…
The significance of maintaining health and well-being cannot be overstated, especially for individuals living with epilepsy, where the impacts of poor physical health, mental well-being, and overall quality of life can be particularly profound. Contrary to common misconceptions, research has…
Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Jolly Good Inc. (Jolly Good) have commenced the delivery of innovative content aimed at supporting families of individuals in Japan grappling with severe social withdrawal (hikikomori) through the utilization of the social skills training…
Sanofi’s Leading Role in Addressing Inflammatory Diseases Highlighted at AAAAI Conference The latest data presented at the American Academy of Allergy Asthma and Immunology (AAAAI) Annual Meeting sheds light on Sanofi’s robust scientific leadership in managing inflammatory diseases. Among the…
Biogen to Reallocate Resources for Alzheimer’s Disease Franchise Growth Strategy” Biogen Inc. (Nasdaq: BIIB) has unveiled plans to strategically reallocate resources in the Alzheimer’s disease (AD) therapeutic area to drive both short-term and long-term growth. The focus will remain on…
